Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Why this matters for the pharma industry: Expands access to GLP-1 therapies in one of the worlds largest healthcare markets Strengthens Pfizers presence in the metabolic disease space Highlights continued regulatory momentum for obesity treatments globally Signals strong commercial potential in the fast-growing GLP-1 market With obesity rates rising worldwide, GLP-1 therapies are becoming one of the most competitive and valuable segments in modern drug development
NSAIDs, Nonsteroidal Anti-Inflammatory Drugs
allow to air dry completely
"We're seeing widespread use of these medications among women of childbearing age, but very little evidence that contraception is being considered as part of routine care," said paper author and pharmacist professor Luke Grzeskowiak in a statement
JAMA Netw Open 2024;7:e2350408.ArticlePubMedPMC 63
Later reevaluation confirmed autoimmune -cell destruction
